|
1
|
American Thoracic Society; European
Respiratory Society: American thoracic society/European respiratory
society international multidisciplinary consensus classification of
the idiopathic interstitial pneumonias. This joint statement of the
American thoracic society (ATS), and the European respiratory
society (ERS) was adopted by the ATS board of directors, June 2001
and by the ERS Executive Committee, June 2001. Am J Respir Crit
Care Med. 165:277–304. 2002. View Article : Google Scholar
|
|
2
|
Wijsenbeek M, Suzuki A and Maher TM:
Interstitial lung diseases. Lancet. 400:769–786. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luppi F, Kalluri M, Faverio P, Kreuter M
and Ferrara G: Idiopathic pulmonary fibrosis beyond the lung:
Understanding disease mechanisms to improve diagnosis and
management. Respir Res. 22:1092021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maher TM, Bendstrup E, Dron L, Langley J,
Smith G, Khalid JM, Patel H and Kreuter M: Global incidence and
prevalence of idiopathic pulmonary fibrosis. Respir Res.
22:1972021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hutchinson J, Fogarty A, Hubbard R and
McKeever T: Global incidence and mortality of idiopathic pulmonary
fibrosis: A systematic review. Eur Respir J. 46:795–806. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Borchers AT, Chang C, Keen CL and Gershwin
ME: Idiopathic pulmonary fibrosis-an epidemiological and
pathological review. Clin Rev Allergy Immunol. 40:117–134. 2011.
View Article : Google Scholar
|
|
7
|
Richeldi L, Collard HR and Jones MG:
Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Podolanczuk AJ, Wong AW, Saito S, Lasky
JA, Ryerson CJ and Eickelberg O: Update in interstitial lung
disease 2020. Am J Respir Crit Care Med. 203:1343–1352. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J and Liu Y: Epithelial stem cells
and niches in lung alveolar regeneration and diseases. Chin Med J
Pulm Crit Care Med. 2:17–26. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv Q, Wang J, Xu C, Huang X, Ruan Z and
Dai Y: Pirfenidone alleviates pulmonary fibrosis in vitro and in
vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3
signaling pathways. Mol Med. 26:492020. View Article : Google Scholar
|
|
11
|
Pan L, Cheng Y, Yang W, Wu X, Zhu H, Hu M,
Zhang Y and Zhang M: Nintedanib ameliorates bleomycin-induced
pulmonary fibrosis, inflammation, apoptosis, and oxidative stress
by modulating PI3K/Akt/mTOR pathway in mice. Inflammation.
46:1531–1542. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Acosta-Plasencia M, Castellano JJ, Díaz T,
He Y, Marrades RM and Navarro A: Discovering genes and microRNAs
involved in human lung development unveils IGFBP3/miR-34a dynamics
and their relevance for alveolar differentiation. Stem Cell Res
Ther. 15:2632024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujino N, Kubo H, Suzuki T, Ota C, Hegab
AE, He M, Suzuki S, Suzuki T, Yamada M, Kondo T, et al: Isolation
of alveolar epithelial type II progenitor cells from adult human
lungs. Lab Invest. 91:363–378. 2011. View Article : Google Scholar :
|
|
14
|
Ruaro B, Salton F, Braga L, Wade B,
Confalonieri P, Volpe MC, Baratella E, Maiocchi S and Confalonieri
M: The history and mystery of alveolar epithelial type II cells:
Focus on their physiologic and pathologic role in lung. Int J Mol
Sci. 22:25662021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Q and Liu Y: Heterogeneous groups of
alveolar type II cells in lung homeostasis and repair. Am J Physiol
Cell Physiol. 319:C991–C996. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu A and Song H: Regulation of alveolar
type 2 stem/progenitor cells in lung injury and regeneration. Acta
Biochim Biophys Sin (Shanghai). 52:716–722. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hogan BLM, Barkauskas CE, Chapman HA,
Epstein JA, Jain R, Hsia CCW, Niklason L, Calle E, Le A, Randell
SH, et al: Repair and regeneration of the respiratory system:
Complexity, plasticity, and mechanisms of lung stem cell function.
Cell Stem Cell. 15:123–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu K, Meng X, Liu Z, Tang M, Lv Z, Huang
X, Jin H, Han X, Liu X, Pu W, et al: Tracing the origin of alveolar
stem cells in lung repair and regeneration. Cell.
187:2428–2445.e20. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Desai TJ, Brownfield DG and Krasnow MA:
Alveolar progenitor and stem cells in lung development, renewal and
cancer. Nature. 507:190–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin C, Chen Y, Wang Y, Li J, Liang J,
Zheng S, Zhang L, Li Q, Wang Y, Ling F, et al: Single-cell RNA
sequencing reveals special basal cells and fibroblasts in
idiopathic pulmonary fibrosis. Sci Rep. 14:157782024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Z, Yang Y, Han X and Hou J: Novel AT2
cell subpopulations and diagnostic biomarkers in IPF: Integrating
machine learning with single-cell analysis. Int J Mol Sci.
25:77542024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chong L, Ahmadvand N, Noori A, Lv Y, Chen
C, Bellusci S and Zhang JS: Injury activated alveolar progenitors
(IAAPs): The underdog of lung repair. Cell Mol Life Sci.
80:1452023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahmadvand N, Khosravi F, Lingampally A,
Wasnick R, Vazquez-Armendariz AI, Carraro G, Heiner M, Rivetti S,
Lv Y, Wilhelm J, et al: Identification of a novel subset of
alveolar type 2 cells enriched in PD-L1 and expanded following
pneumonectomy. Eur Respir J. 58:20041682021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmadvand N, Lingampally A, Khosravi F,
Vazquez-Armendariz AI, Rivetti S, Jones MR, Wilhelm J, Herold S,
Barreto G, Koepke J, et al: Fgfr2b signaling is essential for the
maintenance of the alveolar epithelial type 2 lineage during lung
homeostasis in mice. Cell Mol Life Sci. 79:3022022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ali G, Zhang M, Chang J, Zhao R, Jin Y,
Zhang J and Ji HL: PAI-1 regulates AT2-mediated re-alveolarization
and ion permeability. Stem Cell Res Ther. 14:1852023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Q, Suresh Kumar V, Finn J, Jiang D,
Liang J, Zhao YY and Liu Y: CD44high alveolar type II
cells show stem cell properties during steady-state alveolar
homeostasis. Am J Physiol Lung Cell Mol Physiol. 313:L41–L51. 2017.
View Article : Google Scholar
|
|
27
|
Borrego F: The CD300 molecules: An
emerging family of regulators of the immune system. Blood.
121:1951–1960. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wasnick RM, Shalashova I, Wilhelm J,
Khadim A, Schmidt N, Hackstein H, Hecker A, Hoetzenecker K, Seeger
W, Bellusci S, et al: Differential lysotracker uptake defines two
populations of distal epithelial cells in idiopathic pulmonary
fibrosis. Cells. 11:2352022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Olajuyin AM, Zhang X and Ji HL: Alveolar
type 2 progenitor cells for lung injury repair. Cell Death Discov.
5:632019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aspal M and Zemans RL: Mechanisms of
ATII-to-ATI cell differentiation during lung regeneration. Int J
Mol Sci. 21:31882020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Kumar VS, Zhang W, Rehman J and
Malik AB: Activation of type II cells into regenerative stem cell
antigen-1(+) cells during alveolar repair. Am J Respir Cell Mol
Biol. 53:113–124. 2015. View Article : Google Scholar
|
|
32
|
Basil MC, Katzen J, Engler AE, Guo M,
Herriges MJ, Kathiriya JJ, Windmueller R, Ysasi AB, Zacharias WJ,
Chapman HA, et al: The cellular and physiological basis for lung
repair and regeneration: Past, present, and future. Cell Stem Cell.
26:482–502. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nabhan AN, Brownfield DG, Harbury PB,
Krasnow MA and Desai TJ: Single-cell Wnt signaling niches maintain
stemness of alveolar type 2 cells. Science. 359:1118–1123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frank DB, Peng T, Zepp JA, Snitow M,
Vincent TL, Penkala IJ, Cui Z, Herriges MJ, Morley MP, Zhou S, et
al: Emergence of a wave of Wnt signaling that regulates lung
alveologenesis by controlling epithelial self-renewal and
differentiation. Cell Rep. 17:2312–2325. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Xu Z, Chen Q and Zhou Z: Notch
signaling regulates pulmonary fibrosis. Front Cell Dev Biol.
12:14500382024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wasnick R, Korfei M, Piskulak K, Henneke
I, Wilhelm J, Mahavadi P, Dartsch RC, von der Beck D, Koch M,
Shalashova I, et al: Notch1 induces defective epithelial surfactant
processing and pulmonary fibrosis. Am J Respir Crit Care Med.
207:283–299. 2023. View Article : Google Scholar
|
|
37
|
Finn J, Sottoriva K, Pajcini KV,
Kitajewski JK, Chen C, Zhang W, Malik AB and Liu Y: Dlk1-mediated
temporal regulation of notch signaling is required for
differentiation of alveolar type II to type I cells during repair.
Cell Rep. 26:2942–2954.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kiyokawa H and Morimoto M: Notch signaling
in the mammalian respiratory system, specifically the trachea and
lungs, in development, homeostasis, regeneration, and disease. Dev
Growth Differ. 62:67–79. 2020. View Article : Google Scholar :
|
|
39
|
Frum T, Hsu PP, Hein RFC, Conchola AS,
Zhang CJ, Utter OR, Anand A, Zhang Y, Clark SG, Glass I, et al:
Opposing roles for TGFβ- and BMP-signaling during nascent alveolar
differentiation in the developing human lung. NPJ Regen Med.
8:482023. View Article : Google Scholar
|
|
40
|
Chung MI, Bujnis M, Barkauskas CE,
Kobayashi Y and Hogan BLM: Niche-mediated BMP/SMAD signaling
regulates lung alveolar stem cell proliferation and
differentiation. Development. 145:dev1630142018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yanagihara T, Zhou Q, Tsubouchi K, Revill
S, Ayoub A, Gholiof M, Chong SG, Dvorkin-Gheva A, Ask K, Shi W and
Kolb MR: Intrinsic BMP inhibitor Gremlin regulates alveolar
epithelial type II cell proliferation and differentiation. Biochem
Biophys Res Commun. 656:53–62. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lu W and Kang Y: Epithelial-mesenchymal
plasticity in cancer progression and metastasis. Dev Cell.
49:361–374. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu X, Dai K, Zhang X, Huang G, Lynn H,
Rabata A, Liang J, Noble PW and Jiang D: Multiple fibroblast
subtypes contribute to matrix deposition in pulmonary fibrosis. Am
J Respir Cell Mol Biol. 69:45–56. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Quaggin SE and Kapus A: Scar wars: Mapping
the fate of epithelial-mesenchymal-myofibroblast transition. Kidney
Int. 80:41–50. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Henderson NC, Rieder F and Wynn TA:
Fibrosis: From mechanisms to medicines. Nature. 587:555–566. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tarbit E, Singh I, Peart JN and Rose'Meyer
RB: Biomarkers for the identification of cardiac fibroblast and
myofibroblast cells. Heart Fail Rev. 24:1–15. 2019. View Article : Google Scholar
|
|
49
|
Sun KH, Chang Y, Reed NI and Sheppard D:
α-Smooth muscle actin is an inconsistent marker of fibroblasts
responsible for force-dependent TGFβ activation or collagen
production across multiple models of organ fibrosis. Am J Physiol
Lung Cell Mol Physiol. 310:L824–L836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
TGF-β: The master regulator of fibrosis. Nat Rev Nephrol.
12:325–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu F, Lagares D, Choi KM, Stopfer L,
Marinković A, Vrbanac V, Probst CK, Hiemer SE, Sisson TH, Horowitz
JC, et al: Mechanosignaling through YAP and TAZ drives fibroblast
activation and fibrosis. Am J Physiol Lung Cell Mol Physiol.
308:L344–L357. 2015. View Article : Google Scholar
|
|
52
|
Enomoto Y, Katsura H, Fujimura T, Ogata A,
Baba S, Yamaoka A, Kihara M, Abe T, Nishimura O, Kadota M, et al:
Autocrine TGF-β-positive feedback in profibrotic AT2-lineage cells
plays a crucial role in non-inflammatory lung fibrogenesis. Nat
Commun. 14:49562023. View Article : Google Scholar
|
|
53
|
van Staalduinen J, Baker D, Ten Dijke P
and van Dam H: Epithelial-mesenchymal-transition-inducing
transcription factors: New targets for tackling chemoresistance in
cancer? Oncogene. 37:6195–6211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang J, Tian XJ and Xing J: Signal
transduction pathways of EMT induced by TGF-β, SHH, and WNT and
their crosstalks. J Clin Med. 5:412016. View Article : Google Scholar
|
|
55
|
Hu B and Phan SH: Notch in fibrosis and as
a target of anti-fibrotic therapy. Pharmacol Res. 108:57–64. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hewlett JC, Kropski JA and Blackwell TS:
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions
and emerging therapeutic targets. Matrix Biol. 71-72:112–127. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Collard HR: The age of idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 181:771–772. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Selman M and Pardo A: Revealing the
pathogenic and aging-related mechanisms of the enigmatic idiopathic
pulmonary fibrosis. an integral model. Am J Respir Crit Care Med.
189:1161–1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xu Y, Mizuno T, Sridharan A, Du Y, Guo M,
Tang J, Wikenheiser-Brokamp KA, Perl AT, Funari VA, Gokey JJ, et
al: Single-cell RNA sequencing identifies diverse roles of
epithelial cells in idiopathic pulmonary fibrosis. JCI Insight.
1:e905582016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Snetselaar R, van Batenburg AA, van
Oosterhout MFM, Kazemier KM, Roothaan SM, Peeters T, van der Vis
JJ, Goldschmeding R, Grutters JC and van Moorsel CHM: Short
telomere length in IPF lung associates with fibrotic lesions and
predicts survival. PLoS One. 12:e01894672017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Suryadevara V, Hudgins AD, Rajesh A,
Pappalardo A, Karpova A, Dey AK, Hertzel A, Agudelo A, Rocha A,
Soygur B, et al: SenNet recommendations for detecting senescent
cells in different tissues. Nat Rev Mol Cell Biol. 25:1001–1023.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Parimon T, Hohmann MS and Yao C: Cellular
senescence: Pathogenic mechanisms in lung fibrosis. Int J Mol Sci.
22:62142021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Parikh P, Wicher S, Khandalavala K,
Pabelick CM, Britt RD Jr and Prakash YS: Cellular senescence in the
lung across the age spectrum. Am J Physiol Lung Cell Mol Physiol.
316:L826–L842. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang B, Han J, Elisseeff JH and Demaria M:
The senescence-associated secretory phenotype and its physiological
and pathological implications. Nat Rev Mol Cell Biol. 25:958–978.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mebratu YA, Soni S, Rosas L, Rojas M,
Horowitz JC and Nho R: The aged extracellular matrix and the
profibrotic role of senescence-associated secretory phenotype. Am J
Physiol Cell Physiol. 325:C565–C579. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Borok Z, Horie M, Flodby P, Wang H, Liu Y,
Ganesh S, Firth AL, Minoo P, Li C, Beers MF, et al: Grp78 loss in
epithelial progenitors reveals an age-linked role for endoplasmic
reticulum stress in pulmonary fibrosis. Am J Respir Crit Care Med.
201:198–211. 2020. View Article : Google Scholar
|
|
67
|
Lawson WE, Cheng DS, Degryse AL, Tanjore
H, Polosukhin VV, Xu XC, Newcomb DC, Jones BR, Roldan J, Lane KB,
et al: Endoplasmic reticulum stress enhances fibrotic remodeling in
the lungs. Proc Natl Acad Sci USA. 108:10562–10567. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ali M, Zhang X, LaCanna R, Tomar D, Elrod
JW and Tian Y: MICU1-dependent mitochondrial calcium uptake
regulates lung alveolar type 2 cell plasticity and lung
regeneration. JCI Insight. 7:e1544472022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kim SJ, Cheresh P, Jablonski RP, Williams
DB and Kamp DW: The role of mitochondrial DNA in mediating alveolar
epithelial cell apoptosis and pulmonary fibrosis. Int J Mol Sci.
16:21486–21519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Watson JK, Sanders P, Dunmore R, Rosignoli
G, Julé Y, Rawlins EL, Mustelin T, May R, Clarke D and Finch DK:
Distal lung epithelial progenitor cell function declines with age.
Sci Rep. 10:104902020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bueno M, Calyeca J, Rojas M and Mora AL:
Mitochondria dysfunction and metabolic reprogramming as drivers of
idiopathic pulmonary fibrosis. Redox Biol. 33:1015092020.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Verheyden JM and Sun X: A transitional
stem cell state in the lung. Nat Cell Biol. 22:1025–1026. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kobayashi Y, Tata A, Konkimalla A, Katsura
H, Lee RF, Ou J, Banovich NE, Kropski JA and Tata PR: Persistence
of a regeneration-associated, transitional alveolar epithelial cell
state in pulmonary fibrosis. Nat Cell Biol. 22:934–946. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Shen M, Luo Z and Zhou Y:
Regeneration-associated transitional state cells in pulmonary
fibrosis. Int J Mol Sci. 23:67572022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wu H, Yu Y, Huang H, Hu Y, Fu S, Wang Z,
Shi M, Zhao X, Yuan J, Li J, et al: Progressive pulmonary fibrosis
is caused by elevated mechanical tension on alveolar stem cells.
Cell. 180:107–121.e17. 2020. View Article : Google Scholar
|
|
76
|
George PM, Patterson CM, Reed AK and
Thillai M: Lung transplantation for idiopathic pulmonary fibrosis.
Lancet Respir Med. 7:271–282. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wijsenbeek M and Cottin V: Spectrum of
fibrotic lung diseases. N Engl J Med. 383:958–968. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhang S, Wang Y, Luo D, Cheng Z, Zeng Q,
Wang G, Chen M, Zhang S and Luo P: Pirfenidone inhibits
TGF-β1-induced metabolic reprogramming during
epithelial-mesenchymal transition in non-small cell lung cancer. J
Cell Mol Med. 28:e180592024. View Article : Google Scholar
|
|
79
|
Ying H, Fang M, Hang QQ, Chen Y, Qian X
and Chen M: Pirfenidone modulates macrophage polarization and
ameliorates radiation-induced lung fibrosis by inhibiting the
TGF-β1/Smad3 pathway. J Cell Mol Med. 25:8662–8675. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wollin L, Wex E, Pautsch A, Schnapp G,
Hostettler KE, Stowasser S and Kolb M: Mode of action of nintedanib
in the treatment of idiopathic pulmonary fibrosis. Eur Respir J.
45:1434–1445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Li LF, Kao KC, Liu YY, Lin CW, Chen NH,
Lee CS, Wang CW and Yang CT: Nintedanib reduces
ventilation-augmented bleomycin-induced epithelial-mesenchymal
transition and lung fibrosis through suppression of the Src
pathway. J Cell Mol Med. 21:2937–2949. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ihara H, Mitsuishi Y, Kato M, Takahashi F,
Tajima K, Hayashi T, Hidayat M, Winardi W, Wirawan A, Hayakawa D,
et al: Nintedanib inhibits epithelial-mesenchymal transition in
A549 alveolar epithelial cells through regulation of the TGF-β/Smad
pathway. Respir Investig. 58:275–284. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Noble PW, Albera C, Bradford WZ, Costabel
U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA,
Szwarcberg J, et al: Pirfenidone in patients with idiopathic
pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet.
377:1760–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Richeldi L, du Bois RM, Raghu G, Azuma A,
Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y,
et al: Efficacy and safety of nintedanib in idiopathic pulmonary
fibrosis. N Engl J Med. 370:2071–2082. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Serrano-Mollar A, Nacher M, Gay-Jordi G,
Closa D, Xaubet A and Bulbena O: Intratracheal transplantation of
alveolar type II cells reverses bleomycin-induced lung fibrosis. Am
J Respir Crit Care Med. 176:1261–1268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Aono Y, Ledford JG, Mukherjee S, Ogawa H,
Nishioka Y, Sone S, Beers MF, Noble PW and Wright JR: Surfactant
protein-D regulates effector cell function and fibrotic lung
remodeling in response to bleomycin injury. Am J Respir Crit Care
Med. 185:525–536. 2012. View Article : Google Scholar
|
|
87
|
Liu Y, Leslie PL and Zhang Y: Life and
death decision-making by p53 and implications for cancer
immunotherapy. Trends Cancer. 7:226–239. 2021. View Article : Google Scholar
|
|
88
|
Pawge G and Khatik GL: p53 regulated
senescence mechanism and role of its modulators in age-related
disorders. Biochem Pharmacol. 190:1146512021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Huang Y, Che X, Wang PW and Qu X: p53/MDM2
signaling pathway in aging, senescence and tumorigenesis. Semin
Cancer Biol. 101:44–57. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Sheekey E and Narita M: p53 in
senescence-it's a marathon, not a sprint. FEBS J. 290:1212–1220.
2023. View Article : Google Scholar
|
|
91
|
Yao C, Guan X, Carraro G, Parimon T, Liu
X, Huang G, Mulay A, Soukiasian HJ, David G, Weigt SS, et al:
Senescence of alveolar type 2 cells drives progressive pulmonary
fibrosis. Am J Respir Crit Care Med. 203:707–717. 2021. View Article : Google Scholar
|
|
92
|
Wu D and Prives C: Relevance of the
p53-MDM2 axis to aging. Cell Death Differ. 25:169–179. 2018.
View Article : Google Scholar
|
|
93
|
Nagaraja MR, Tiwari N, Shetty SK,
Marudamuthu AS, Fan L, Ostrom RS, Fu J, Gopu V, Radhakrishnan V,
Idell S and Shetty S: p53 expression in lung fibroblasts is linked
to mitigation of fibrotic lung remodeling. Am J Pathol.
188:2207–2222. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Khattak S, Zhang QQ, Sarfraz M, Muhammad
P, Ngowi EE, Khan NH, Rauf S, Wang YZ, Qi HW, Wang D, et al: The
role of hydrogen sulfide in respiratory diseases. Biomolecules.
11:6822021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hou J, Huang Y, Fu L, Sun M, Wang L, Guo
R, Chen L and Lv C: Evaluating the effect of hydrogen sulfide in
the idiopathic pulmonary fibrosis model with a fluorescent probe.
Anal Chem. 95:5514–5521. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang XL, Xu YT, Zhang SL, Zhu XY, Zhang HX
and Liu YJ: Hydrogen sulfide inhibits alveolar type II cell
senescence and limits pulmonary fibrosis via promoting
MDM2-mediated p53 degradation. Acta Physiol (Oxf). 240:e140592024.
View Article : Google Scholar
|
|
97
|
Wang X, Zhu Y, Liu H, Wang X, Zhang H and
Chen X: Nitazoxanide alleviates experimental pulmonary fibrosis by
inhibiting the development of cellular senescence. Life Sci.
361:1233022025. View Article : Google Scholar
|
|
98
|
Zhang C, Chen L, Xie C, Wang F, Wang J,
Zhou H, Liu Q, Zeng Z, Li N, Huang J, et al: YTHDC1 delays cellular
senescence and pulmonary fibrosis by activating ATR in an
m6A-independent manner. EMBO J. 43:61–86. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Hu L, Li H, Zi M, Li W, Liu J, Yang Y,
Zhou D, Kong QP, Zhang Y and He Y: Why Senescent cells are
resistant to apoptosis: An insight for senolytic development. Front
Cell Dev Biol. 10:8228162022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Soto-Gamez A, Quax WJ and Demaria M:
Regulation of survival networks in senescent cells: From mechanisms
to interventions. J Mol Biol. 431:2629–2643. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Olascoaga S, Konigsberg M,
Espinal-Enríquez J, Tovar H, Matadamas-Martínez F, Pérez-Villanueva
J and López-Diazguerrero NE: Transcriptomic signatures and
network-based methods uncover new senescent cell anti-apoptotic
pathways and senolytics. FEBS J. 292:1950–1971. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Martel J, Ojcius DM, Wu CY, Peng HH,
Voisin L, Perfettini JL, Ko YF and Young JD: Emerging use of
senolytics and senomorphics against aging and chronic diseases. Med
Res Rev. 40:2114–2131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Power H, Valtchev P, Dehghani F and
Schindeler A: Strategies for senolytic drug discovery. Aging Cell.
22:e139482023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang L, Pitcher LE, Prahalad V,
Niedernhofer LJ and Robbins PD: Targeting cellular senescence with
senotherapeutics: Senolytics and senomorphics. FEBS J.
290:1362–1383. 2023. View Article : Google Scholar
|
|
105
|
Nambiar A, Kellogg D III, Justice J, Goros
M, Gelfond J, Pascual R, Hashmi S, Masternak M, Prata L, LeBrasseur
N, et al: Senolytics dasatinib and quercetin in idiopathic
pulmonary fibrosis: Results of a phase I, single-blind,
single-center, randomized, placebo-controlled pilot trial on
feasibility and tolerability. EBioMedicine. 90:1044812023.
View Article : Google Scholar
|
|
106
|
Pan J, Li D, Xu Y, Zhang J, Wang Y, Chen
M, Lin S, Huang L, Chung EJ, Citrin DE, et al: Inhibition of
Bcl-2/xl with ABT-263 selectively kills senescent type II
pneumocytes and reverses persistent pulmonary fibrosis induced by
ionizing radiation in mice. Int J Radiat Oncol Biol Phys.
99:353–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhang X, Dong Y, Li WC, Tang BX, Li J and
Zang Y: Roxithromycin attenuates bleomycin-induced pulmonary
fibrosis by targeting senescent cells. Acta Pharmacol Sin.
42:2058–2068. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li XN, Lin YP, Han MM, Fang YF, Xing L,
Jeong JH and Jiang HL: Modulating fibrotic mechanical
microenvironment for idiopathic pulmonary fibrosis therapy. Adv
Mater. 36:e24076612024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Milman Krentsis I, Zheng Y, Rosen C, Shin
SY, Blagdon C, Shoshan E, Qi Y, Wang J, Yadav SK, Bachar Lustig E,
et al: Lung cell transplantation for pulmonary fibrosis. Sci Adv.
10:eadk25242024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lopez-Rodriguez E, Gay-Jordi G, Knudsen L,
Ochs M and Serrano-Mollar A: Improved alveolar dynamics and
structure after alveolar epithelial type II cell transplantation in
bleomycin induced lung fibrosis. Front Med (Lausanne).
8:6400202021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Herriges MJ, Yampolskaya M, Thapa BR,
Lindstrom-Vautrin J, Wang F, Huang J, Na CL, Ma L, Montminy MM,
Bawa P, et al: Durable alveolar engraftment of PSC-derived lung
epithelial cells into immunocompetent mice. Cell Stem Cell.
30:1217–1234.e7. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Mansouri N, Willis GR, Fernandez-Gonzalez
A, Reis M, Nassiri S, Mitsialis SA and Kourembanas S: Mesenchymal
stromal cell exosomes prevent and revert experimental pulmonary
fibrosis through modulation of monocyte phenotypes. JCI Insight.
4:e1280602019. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Averyanov A, Koroleva I, Konoplyannikov M,
Revkova V, Lesnyak V, Kalsin V, Danilevskaya O, Nikitin A,
Sotnikova A, Kotova S and Baklaushev V: First-in-human
high-cumulative-dose stem cell therapy in idiopathic pulmonary
fibrosis with rapid lung function decline. Stem Cells Transl Med.
9:6–16. 2020. View Article : Google Scholar :
|
|
114
|
Cheng W, Zeng Y and Wang D: Stem
cell-based therapy for pulmonary fibrosis. Stem Cell Res Ther.
13:4922022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Choi SM, Mo Y, Bang JY, Ko YG, Ahn YH, Kim
HY, Koh J, Yim JJ and Kang HR: Classical monocyte-derived
macrophages as therapeutic targets of umbilical cord mesenchymal
stem cells: Comparison of intratracheal and intravenous
administration in a mouse model of pulmonary fibrosis. Respir Res.
24:682023. View Article : Google Scholar : PubMed/NCBI
|
